208 related articles for article (PubMed ID: 16436733)
1. Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.
Delmas J; Robin F; Carvalho F; Mongaret C; Bonnet R
Antimicrob Agents Chemother; 2006 Feb; 50(2):731-8. PubMed ID: 16436733
[TBL] [Abstract][Full Text] [Related]
2. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
3. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
Kimura S; Ishii Y; Tateda K; Yamaguchi K
Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
[TBL] [Abstract][Full Text] [Related]
4. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
[TBL] [Abstract][Full Text] [Related]
5. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
6. Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli.
Karisik E; Ellington MJ; Pike R; Livermore DM; Woodford N
Clin Microbiol Infect; 2006 Aug; 12(8):803-6. PubMed ID: 16842579
[TBL] [Abstract][Full Text] [Related]
7. Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Nagano Y; Nagano N; Wachino J; Ishikawa K; Arakawa Y
Antimicrob Agents Chemother; 2009 Jan; 53(1):69-74. PubMed ID: 18955524
[TBL] [Abstract][Full Text] [Related]
8. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
[TBL] [Abstract][Full Text] [Related]
9. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
Hidri N; Barnaud G; Decré D; Cerceau C; Lalande V; Petit JC; Labia R; Arlet G
J Antimicrob Chemother; 2005 Apr; 55(4):496-9. PubMed ID: 15722393
[TBL] [Abstract][Full Text] [Related]
10. Effect of D240G substitution in a novel ESBL CTX-M-27.
Bonnet R; Recule C; Baraduc R; Chanal C; Sirot D; De Champs C; Sirot J
J Antimicrob Chemother; 2003 Jul; 52(1):29-35. PubMed ID: 12775683
[TBL] [Abstract][Full Text] [Related]
11. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
[TBL] [Abstract][Full Text] [Related]
12. Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43.
Celenza G; Luzi C; Aschi M; Segatore B; Setacci D; Pellegrini C; Forcella C; Amicosante G; Perilli M
J Antimicrob Chemother; 2008 Nov; 62(5):991-7. PubMed ID: 18755695
[TBL] [Abstract][Full Text] [Related]
13. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
[TBL] [Abstract][Full Text] [Related]
14. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
[TBL] [Abstract][Full Text] [Related]
15. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.
Welsh KJ; Barlow M; Tenover FC; Biddle JW; Rasheed JK; Clark LA; McGowan JE
Antimicrob Agents Chemother; 2005 Mar; 49(3):1242-4. PubMed ID: 15728940
[TBL] [Abstract][Full Text] [Related]
16. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
17. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
[TBL] [Abstract][Full Text] [Related]
18. Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum β-Lactamase CTX-M-96.
Ghiglione B; Rodríguez MM; Herman R; Curto L; Dropa M; Bouillenne F; Kerff F; Galleni M; Charlier P; Gutkind G; Sauvage E; Power P
Biochemistry; 2015 Aug; 54(32):5072-82. PubMed ID: 26228623
[TBL] [Abstract][Full Text] [Related]
19. Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains.
Stepanova MN; Pimkin M; Nikulin AA; Kozyreva VK; Agapova ED; Edelstein MV
Antimicrob Agents Chemother; 2008 Apr; 52(4):1297-301. PubMed ID: 18212109
[TBL] [Abstract][Full Text] [Related]
20. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
